SCHEMBL28301005

SCHEMBL28301005

COc1cc(-c2ccnn2-c2ccccc2)ccc1-c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
PDE10A Q9Y233 3/20 0.45
MAPT P10636 4/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 2/20 0.45
HPGDS O60760 1/20 0.45
FYN P06241 2/20 0.43
KDM5A P29375 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
KDM5B Q9UGL1 1/20 0.43
MAPK14 Q16539 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12722869 0.75 PDE10A (0.49) PDE10AMAPTALDH1A1GAAHPGDS
SCHEMBL12722760 0.73 MAPT (0.51) NPC1RAB9APDE10AMAPTALDH1A1
SCHEMBL15557293 0.71 MAPT (0.53) MAPTGAAKDM4ETSHRNR3C2
SCHEMBL1438281 0.71 NPC1 (0.54) NPC1RAB9APDE10AMAPTALDH1A1
SCHEMBL27310701 0.71 MEN1 (0.51) NPC1RAB9AMAPTALDH1A1GAA
SCHEMBL28004022 0.71 MAPK9 (0.54) NPC1RAB9APDE10AALDH1A1KDM5A
SCHEMBL13734610 0.71 ALDH1A1 (0.59) NPC1RAB9AMAPTALDH1A1MAPK14
SCHEMBL28300954 0.70 SMN1; SMN2 (0.50) NPC1RAB9APDE10AMAPTALDH1A1
SCHEMBL3607497 0.70 MAPK9 (0.57) NPC1MAPTALDH1A1GAAHPGDS
SCHEMBL13735225 0.70 MAPK9 (0.51) NPC1RAB9APDE10AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890822-A INHIBITORS OF CELLULAR METABOLIC PROCESSES 安吉奥斯医药品有限公司 2019-06-14 CN disclosed